COLETTE JOSEPH: Open Payments
NPI 1700241718 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 14 payments from 13 companies in 2025. Trend: 2023 $776 · 2024 $912 · 2025 $1,156
Food & beverage: $1,156
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Lilly USA, LLC | 1 | $122 |
| SANOFI-AVENTIS U.S. LLC | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 2 | $117 |
| GlaxoSmithKline, LLC. | 1 | $113 |
| Corcept Therapeutics | 1 | $112 |
| bioMerieux Inc | 1 | $103 |
| Radius Health, Inc. | 1 | $94 |
| Amgen Inc. | 1 | $47 |
Products named: Enhertu, CAPLYTA, ZEPBOUND, TZIELD, OJJAARA, Korlym, Tymlos, IMFINZI.
Industry payments across FL — which companies pay providers there.
